Metraipolis › archive › dc_4ec3ad4447c8

Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection — Europe PMC PMID:42164511

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42164511
DOI
10.3389/fimmu.2026.1787877
License (as archived)
solo-consultazione
Archived
2026-11-02T18:39:25.200Z
SHA-256 of the archived text
645a8c5654403cf0305292928d9a61ccf54e68b8248529aede11054d3479d8fd
Stable URL of this page
https://metraipolis.com/documento/dc_4ec3ad4447c8

How to cite

Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection — Europe PMC PMID:42164511 — Europe PMC (en), https://europepmc.org/article/MED/42164511 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ec3ad4447c8 (Metraipolis archive dc_4ec3ad4447c8, sha256 645a8c5654403cf0305292928d9a61ccf54e68b8248529aede11054d3479d8fd)
BibTeX
@misc{dc4ec3ad4447c8,
  title = {Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection — Europe PMC PMID:42164511},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42164511},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ec3ad4447c8; sha256 645a8c5654403cf0305292928d9a61ccf54e68b8248529aede11054d3479d8fd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42164511. Agents can read the archived copy with the MCP tool read_document.